$11.23
0.27% day before yesterday
Nasdaq, May 30, 07:45 pm CET
ISIN
US0352551081
Symbol
ANIK
Sector
Industry

Anika Therapeutics, Inc. Stock price

$11.15
-3.38 23.26% 1M
-6.40 36.47% 6M
-5.31 32.26% YTD
-14.56 56.63% 1Y
-10.90 49.43% 3Y
-22.76 67.12% 5Y
-22.49 66.85% 10Y
Nasdaq, Closing price Fri, May 30 2025
-0.11 0.98%
ISIN
US0352551081
Symbol
ANIK
Sector
Industry

Key metrics

Market capitalization $159.91m
Enterprise Value $106.54m
P/E (TTM) P/E ratio negative
EV/FCF (TTM) EV/FCF negative
EV/Sales (TTM) EV/Sales 0.78
P/S ratio (TTM) P/S ratio 1.16
P/B ratio (TTM) P/B ratio 1.08
Revenue growth (TTM) Revenue growth -18.80%
Revenue (TTM) Revenue $137.44m
EBIT (operating result TTM) EBIT $-6.40m
Free Cash Flow (TTM) Free Cash Flow $-3.95m
Cash position $53.37m
EPS (TTM) EPS $-3.96
P/E forward negative
P/S forward 1.45
EV/Sales forward 0.97
Short interest 3.34%
Show more

Is Anika Therapeutics, Inc. a Top Scorer Stock based on the Dividend, High-Growth-Investing or Leverman Strategy?

As a Free StocksGuide user, you can view scores for all 6,782 stocks worldwide.

Anika Therapeutics, Inc. Stock Analysis

Unlock Scores for Free

Analyst Opinions

3 Analysts have issued a Anika Therapeutics, Inc. forecast:

3x Buy
100%

Analyst Opinions

3 Analysts have issued a Anika Therapeutics, Inc. forecast:

Buy
100%

Financial data from Anika Therapeutics, Inc.

Income Statement P&L | Balance Sheet | Cash Flow


Quarter TTM Annually
Mar '25
+/-
%
137 137
19% 19%
100%
- Direct Costs 54 54
15% 15%
39%
83 83
21% 21%
61%
- Selling and Administrative Expenses 63 63
28% 28%
45%
- Research and Development Expense 27 27
16% 16%
20%
1.25 1.25
212% 212%
1%
- Depreciation and Amortization 7.65 7.65
40% 40%
6%
EBIT (Operating Income) EBIT -6.40 -6.40
54% 54%
-5%
Net Profit -57 -57
26% 26%
-41%

In millions USD.

Don't miss a Thing! We will send you all news about Anika Therapeutics, Inc. directly to your mailbox free of charge.

If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.

Anika Therapeutics, Inc. Stock News

Neutral
GlobeNewsWire
20 days ago
BEDFORD, Mass., May 12, 2025 (GLOBE NEWSWIRE) -- Anika Therapeutics, Inc. (NASDAQ: ANIK), a global leader in the osteoarthritis (“OA”) pain management and regenerative solutions spaces focused on early intervention orthopedics, today announced that on May 1, 2025, Anika granted non-statutory stock options (“Options”) covering an aggregate of 5,000 shares of common stock at a per share exercise ...
Neutral
Seeking Alpha
23 days ago
Anika Therapeutics, Inc. (NASDAQ:ANIK ) Q1 2025 Earnings Conference Call May 9, 2025 8:30 AM ET Company Participants Matt Hall - Director, Corporate Development & Investor Relations Cheryl Blanchard - President & Chief Executive Officer Steve Griffin - Executive Vice President, Chief Financial Officer & Chief Operating Officer Conference Call Participants Anderson Schock - B. Riley Securities M...
Neutral
GlobeNewsWire
23 days ago
First Quarter 2025 Commercial Channel revenue up 18% Integrity ™ Implant System continues sequential growth and is on pace to more than double procedures in 2025 Key regulatory and clinical milestones achieved for Hyalofast®, Cingal®, and Integrity Updating Fiscal 2025 OEM Channel revenue guidance and Adjusted EBITDA guidance BEDFORD, Mass., May 09, 2025 (GLOBE NEWSWIRE) -- Anika Therapeutics, ...
More Anika Therapeutics, Inc. News

Company Profile

Anika Therapeutics, Inc. is an orthopedic and regenerative medicines company, which develops, manufactures and commercializes therapeutic products for pain management, tissue regeneration, and wound healing. Its products are based on hyaluronic acid, a natural chemical occurring, biocompatible polymer found throughout the body. It offers therapeutic products which include orthobiologics, dermal, ophthalmic, surgical, ophthalmic and veterinary. The company was founded in 1992 and is headquartered in Bedford, MA.

Head office United States
CEO Cheryl Blanchard
Employees 288
Founded 1992
Website anika.com

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today